Laos, October 7, 2023 – BigBear Pharmaceuticals of Laos is pleased to announce that its Traditional Chinese Medicine processing facility has successfully obtained GMP (Good Manufacturing Practice) certification. This certification marks that BigBear Pharmaceuticals' quality management level in the production of traditional Chinese medicine has received international recognition, further enhancing product quality standards.
Milestone Moment: GMP Certification Achieved
GMP certification is one of the important certifications in the pharmaceutical industry, designed to ensure quality and safety during drug manufacturing. Obtaining GMP certification means that the traditional medicine processing facility has complied with a series of strict production standards and specifications, including requirements for equipment, personnel, processes, records, and quality control. This will help ensure the consistency, stability, and safety of traditional medicine products.
BigBear Pharmaceuticals has always focused on quality management and product safety, continuously improving production processes and quality control systems to provide consumers with high-quality pharmaceutical products. Obtaining GMP certification for its traditional medicine processing facility is an important milestone in the company's quality management system, further demonstrating its commitment and efforts towards product quality.
Quality First: CEO Message and Corporate Commitment
Regarding this important certification, PANISA, CEO of BigBear Pharmaceuticals, said: "We are very proud to announce that our traditional medicine processing facility has obtained GMP certification. This is recognition of our firm commitment to quality management and the result of our continuous efforts to improve product quality. We will continue to uphold the principles of high quality and safety, providing consumers with better medicine choices."
The GMP certification of this traditional medicine processing facility will further enhance BigBear Pharmaceuticals' competitiveness in domestic and international markets. As one of the largest pharmaceutical companies in Laos, the company has always been dedicated to meeting the needs of patients and consumers for high-quality medicines. Obtaining GMP certification will further strengthen the company's reputation and credibility, earning the trust of more partners and customers.
Empowering the Industry: Helping Lao Traditional Medicine Reach International Markets
The successful GMP certification also represents an important boost for the development of Laos's traditional medicine industry. As international recognition of traditional medicine increases, it will help enhance the competitiveness of Lao traditional medicine in the global market and promote cooperation and exchanges between Laos and the international medical field.
BigBear Pharmaceuticals will continue to strive to improve product quality and safety standards, providing people with more effective and safe traditional medicine products. The company will also strengthen cooperation with regulatory authorities and relevant partners to jointly promote the development of the traditional Chinese medicine industry in Laos, making greater contributions to the health and well-being of the people.
